Quest Diagnostics Inc posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26. Sales increased 8.5% year-over-year to $2.49 billion, beating the consensus of $2.42 billion. Quest Diagnostics ( DGX ) saw total revenue growth of 8.5%, including 4.2% organic growth, said Quest Diagnostics CEO Jim Davis. “Our performance was driven by new customer wins and expanded business with physicians...

11:13 AM EDT, 10/22/2024 (MT Newswires) -- Hesai Technology said Tuesday it will exclusively supply long-range lidar for Leapmotor's new models, with the first model slated for mass production in 2025. Under the agreement, Hesai ( HSAI ) said it will provide lidar systems for multiple upcoming models, expanding the companies' collaboration on intelligent driving systems. Hesai ( HSAI )...

* DOE announced $1.7 billion in grants for EV plant conversions * UAW threatens strikes over Stellantis ( STLA ) delays in Belvidere investment * Granholm emphasizes Biden administration's commitment to EV production By David Shepardson, Nora Eckert DETROIT, Oct 22 (Reuters) - U.S. Energy Secretary Jennifer Granholm said Tuesday the department is working as fast as we can to...

11:10 AM EDT, 10/22/2024 (MT Newswires) -- Sangamo Therapeutics ( SGMO ) shares surged past 31% in recent Tuesday trading after the genomic medicine company said the US Food and Drug Administration has laid out a clear pathway for accelerated approval for its ST-920 gene therapy candidate for the treatment of Fabry disease. Fabry disease is a genetic condition characterized...